Neuroone Medical Technologies (NMTC) Liabilities from Discontinued Operations (2015 - 2016)
Neuroone Medical Technologies' (NMTC) quarterly Liabilities from Discontinued Operations came in at $21807.0 in Q4 2016, up 10.02% on a YoY basis from $19821.0 in Q1 2016, and little changed quarter-over-quarter from $21807.0 in Q3 2016.
Powered by 
Analysis
Neuroone Medical Technologies (NMTC) Liabilities from Discontinued Operations (2015 - 2016) Analysis & Trends
Neuroone Medical Technologies (NMTC) has reported Liabilities from Discontinued Operations for 2 consecutive years, with $21807.0 the latest figure, recorded in Q4 2016.
- For the quarter ending Q4 2016, Liabilities from Discontinued Operations rose 10.02% year-over-year to $21807.0; the trailing twelve-month figure through Dec 2016 stood at $21807.0 (up 10.02% YoY), and the FY2016 full-year result was $21807.0, up 10.02% from the prior year.
- Liabilities from Discontinued Operations steadied at $21807.0 in Q4 2016 per NMTC's latest filing, from $21807.0 in the prior quarter.
- Across five years, Liabilities from Discontinued Operations topped out at $21807.0 in Q2 2016 and bottomed at $19821.0 in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Neuroone Medical Technologies | 14.10 Mn | 12.05 Mn | 1.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | 21,807.00 |
| Sep 30, 2016 | 21,807.00 |
| Jun 30, 2016 | 21,807.00 |
| Dec 31, 2015 | 19,821.00 |